CVS Health made a net profit of USD 2,975 mil with revenues of USD 65,341 mil in 2Q2020, up by 53.7% and up by 3.01%, respectively, compared to the previous year. This translates into a net margin of 4.55%.
On the operating level, EBITDA reached USD 5,782 mil, up 13.9% compared to the previous year. Over the last five years, the company's EBITDA has risen 16.0% a year on average.
The company generated cash, defined by a sum of net profit and depreciation, of USD 3,481 mil or 5.33% of sales. When investments are excluded, free cash flow reached USD 5,786 mil, or 8.86% of sales in 2Q2020.
In the last five years, the company generated free cash flow of USD -11,428 mil. That compares to a cumulative net profit of USD 25,705 mil in the same period.